Package 69539-023-05
Brand: deferasirox
Generic: deferasiroxPackage Facts
Identity
Package NDC
69539-023-05
Digits Only
6953902305
Product NDC
69539-023
Description
500 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-05)
Marketing
Marketing Status
Brand
deferasirox
Generic
deferasirox
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4b237031-5375-4a5a-8a5d-21527f6fc7da", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "upc": ["0369539022113", "0369539021994", "0369539021901", "0369539021307", "0369539023110", "0369539022908", "0369539023301", "0369539022991", "0369539023059", "0369539023905", "0369539022304"], "unii": ["V8G4MOF2V9"], "rxcui": ["597768", "597770", "597772"], "spl_set_id": ["e0726c9c-cee8-4fc1-abd1-68ad0db030dd"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["MSN LABORATORIES PRIVATE LIMITED"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-05)", "package_ndc": "69539-023-05", "marketing_start_date": "20191120"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (69539-023-06) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (69539-023-11)", "package_ndc": "69539-023-06", "marketing_start_date": "20200212"}, {"sample": false, "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-30)", "package_ndc": "69539-023-30", "marketing_start_date": "20191120"}, {"sample": false, "description": "90 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-90)", "package_ndc": "69539-023-90", "marketing_start_date": "20191120"}], "brand_name": "Deferasirox", "product_id": "69539-023_4b237031-5375-4a5a-8a5d-21527f6fc7da", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "69539-023", "generic_name": "Deferasirox", "labeler_name": "MSN LABORATORIES PRIVATE LIMITED", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasirox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "500 mg/1"}], "application_number": "ANDA209878", "marketing_category": "ANDA", "marketing_start_date": "20191120", "listing_expiration_date": "20261231"}